No, the primary endpoint is clinical improvement as assessed by change in total symptom score (fever, myalgia, dyspnea and cough). Each is a scale of 0-3, for a total of 12 points.

https://clinicaltrials.gov/ct2/show/NCT043436...amp;rank=2